View in EDS

Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.

Saved in:
Bibliographic Details
Title: Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
Authors: Creasy CA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Meng YJ; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Karpinets T; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas., Tomczak K; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas., Stewart C; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Torres-Cabala CA; Department of Pathology, The University of Texas MDACC, Houston, Texas., Pilon-Thomas S; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Sarnaik AA; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Mulé JJ; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Garraway L; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bustos M; Department of Translational Molecular Medicine, Saint John's Cancer Institute, Saint John's Health Center, Santa Monica, California., Zhang J; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Yee C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., McQuade J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Hoon DSB; Department of Translational Molecular Medicine, Saint John's Cancer Institute, Saint John's Health Center, Santa Monica, California., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Haymaker C; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas., Beroukhim R; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 May 02; Vol. 28 (9), pp. 1911-1924.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35190823
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Creasy+CA%22">Creasy CA</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Meng+YJ%22">Meng YJ</searchLink>; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Forget+MA%22">Forget MA</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Karpinets+T%22">Karpinets T</searchLink>; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Tomczak+K%22">Tomczak K</searchLink>; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Stewart+C%22">Stewart C</searchLink>; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Torres-Cabala+CA%22">Torres-Cabala CA</searchLink>; Department of Pathology, The University of Texas MDACC, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Pilon-Thomas+S%22">Pilon-Thomas S</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Sarnaik+AA%22">Sarnaik AA</searchLink>; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Mulé+JJ%22">Mulé JJ</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Garraway+L%22">Garraway L</searchLink>; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bustos+M%22">Bustos M</searchLink>; Department of Translational Molecular Medicine, Saint John's Cancer Institute, Saint John's Health Center, Santa Monica, California.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Patel+SP%22">Patel SP</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Diab+A%22">Diab A</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Glitza+IC%22">Glitza IC</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Yee+C%22">Yee C</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Tawbi+H%22">Tawbi H</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Wong+MK%22">Wong MK</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22McQuade+J%22">McQuade J</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Hoon+DSB%22">Hoon DSB</searchLink>; Department of Translational Molecular Medicine, Saint John's Cancer Institute, Saint John's Health Center, Santa Monica, California.<br /><searchLink fieldCode="AU" term="%22Davies+MA%22">Davies MA</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Hwu+P%22">Hwu P</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Amaria+RN%22">Amaria RN</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Haymaker+C%22">Haymaker C</searchLink>; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Beroukhim+R%22">Beroukhim R</searchLink>; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bernatchez+C%22">Bernatchez C</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2022 May 02; Vol. 28 (9), pp. 1911-1924.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35190823
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-21-1060
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1911
    Titles:
      – TitleFull: Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Creasy CA
      – PersonEntity:
          Name:
            NameFull: Meng YJ
      – PersonEntity:
          Name:
            NameFull: Forget MA
      – PersonEntity:
          Name:
            NameFull: Karpinets T
      – PersonEntity:
          Name:
            NameFull: Tomczak K
      – PersonEntity:
          Name:
            NameFull: Stewart C
      – PersonEntity:
          Name:
            NameFull: Torres-Cabala CA
      – PersonEntity:
          Name:
            NameFull: Pilon-Thomas S
      – PersonEntity:
          Name:
            NameFull: Sarnaik AA
      – PersonEntity:
          Name:
            NameFull: Mulé JJ
      – PersonEntity:
          Name:
            NameFull: Garraway L
      – PersonEntity:
          Name:
            NameFull: Bustos M
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Patel SP
      – PersonEntity:
          Name:
            NameFull: Diab A
      – PersonEntity:
          Name:
            NameFull: Glitza IC
      – PersonEntity:
          Name:
            NameFull: Yee C
      – PersonEntity:
          Name:
            NameFull: Tawbi H
      – PersonEntity:
          Name:
            NameFull: Wong MK
      – PersonEntity:
          Name:
            NameFull: McQuade J
      – PersonEntity:
          Name:
            NameFull: Hoon DSB
      – PersonEntity:
          Name:
            NameFull: Davies MA
      – PersonEntity:
          Name:
            NameFull: Hwu P
      – PersonEntity:
          Name:
            NameFull: Amaria RN
      – PersonEntity:
          Name:
            NameFull: Haymaker C
      – PersonEntity:
          Name:
            NameFull: Beroukhim R
      – PersonEntity:
          Name:
            NameFull: Bernatchez C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 05
              Text: 2022 May 02
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1